Skip to content

Study of Coffee Mannooligosaccharides for Weight Management

THE EFFECTS OF COFFEE MANNOOLIGOSACCHARIDES ON INDICES OF BODY WEIGHT, BODY COMPOSITION, AND SATIETY IN HUMANS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00932750
Acronym
MOS
Enrollment
82
Registered
2009-07-03
Start date
2006-09-30
Completion date
2007-11-30
Last updated
2012-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Body composition, Weight loss, Weight management, Beverages, Diet

Brief summary

The goal of this study is to establish the role of coffee mannooligosaccharides (MOS), provided in a beverage format, on body weight regulation. Overweight and obese men and women will be randomized to one of 2 groups: placebo or MOS beverage. They will be required to consume 2 beverages/day for the duration of the 2 phases of the study. The MOS beverage will provide 2 g of MOS (total of 4 g/d). This dose level has been found to be well tolerated and safe. In the first phase, subjects will be counseled once monthly on a nutrition-related topic on an individual basis. They will be asked to maintain their regular eating and exercise habits for the duration of the 12 week period. An 8-week washout period will follow during which time they will not be required to consume the beverages. The second phase of the study will be a weight loss phase. For this phase, subjects will be re-randomized and may consume the alternate or the same beverage as the first phase, depending on the outcome of randomization. During this phase, they will undergo group counseling on a weekly basis. Counseling sessions will focus on weight loss and ways to achieve moderate weight loss of approximately 1-2 lbs/week. Measurements will be taken at the beginning and end of each phase. This study will allow us to determine whether MOS helps maintain body weight and prevent weight gain (first phase) and whether it helps to stimulate weight loss (second phase). The results will allow us to find ways in which overweight and obese individuals can incorporate beverages in their diets that will help promote weight loss.

Interventions

DIETARY_SUPPLEMENTCoffee mannooligosaccharide

2 beverages daily providing either 4 g of coffee mannooligosaccharide or placebo.

DIETARY_SUPPLEMENTCoffee mannooligosaccharides

Subjects consume 2 beverages daily providing 4 g of coffee mannooligosaccharides or placebo

Sponsors

St. Luke's-Roosevelt Hospital Center
CollaboratorOTHER
Mondelēz International, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index 27-33 kg/m2 * Stable body weight

Exclusion criteria

* Body width \> 46 cm * Medications known to affect body weight, lipids, blood pressure * Pregnant or lactating women * Less than 1 y post-partum

Design outcomes

Primary

MeasureTime frame
Body Composition by Magnetic Resonance ImagingBaseline and Endpoint
Blood pressureWeekly
Body weightWeekly
Waist circumferenceWeekly

Secondary

MeasureTime frame
Appetite/SatietyWeekly

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026